Dompe Farmaceutici S.p.A.(製薬・医療分野):企業M&A動向

【英語タイトル】Dompe Farmaceutici S.p.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(GDPH182029D)・商品コード:GDPH182029D
・発行会社(調査会社):GlobalData
・発行日:2015年3月16日
・ページ数:27
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:イタリア
・産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary

Dompe Farmaceutici S.p.A. (Dompe) is a biopharmaceutical company. The company conducts research, develops and manufactures and markets pharmaceutical products. Its major focus area is rare and orphan diseases including pulmonary arterial hypertension and rare eye diseases such as neurotrophic keratitis and retinitis pigmentosa. Its other areas of focus include treatments for respiratory diseases such as cough, chronic obstructive pulmonary disease, asthma and rhinitis; osteoarticular disorders, or rheumatic diseases including osteoarthritis and arthritis. The company also offers over-the-counter (OTC) medications for dry cough, headache, sore throat and wet cough. It carries out research and development in the areas of diabetes, organ transplantations, ophthalmology and oncology in collaboration with an international network of 65 research institutes. Dompe has industrial and biotechnological research facilities in L’Aquila, an R&D unit in Naples and a subsidiary in New York. Dompe Farmaceutici is headquartered in Milan, Italy.

Dompe Farmaceutici S.p.A. – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Dompe Farmaceutici S.p.A., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Dompe Farmaceutici S.p.A., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
Dompe Farmaceutici S.p.A., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Dompe Farmaceutici S.p.A., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8
Dompe Farmaceutici S.p.A., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 9
Dompe Farmaceutici S.p.A., Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Advanced Accelerator Secures US$57 Million In Venture Financing 10
Partnerships 12
Dompe Farmaceutici Enters Into Co-Development Agreement With SatRx For Reparixin 12
Dompe Farmaceutici Extends Drug Discovery Collaboration With Axxam 14
Licensing Agreements 15
Scil Proteins Enters Into Licensing Agreement With Anabasis 15
Dompe Enters Into Licensing Agreement With Anabasis 16
Asset Transactions 17
Advanced Accelerator Acquires Rights To Fabovar From Dompe 17
Acquisition 19
Dompe Acquires Remaining 51% Stake In Anabasis 19
Biogen Idec Acquires Remaining JV Stake In Biogen Dompe From Dompe 21
Dompe Farmaceutici Acquires 49% Stake In Anabasis, BioPharma Company 23
Dompe Farmaceutici S.p.A. – Key Competitors 24
Key Employees 25
Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Dompe Farmaceutici S.p.A., Pharmaceuticals & Healthcare, Key Facts 1
Dompe Farmaceutici S.p.A., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Dompe Farmaceutici S.p.A., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015 6
Dompe Farmaceutici S.p.A., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Dompe Farmaceutici S.p.A., Deals By Therapy Area, 2009 to YTD 2015 8
Dompe Farmaceutici S.p.A., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015 9
Advanced Accelerator Secures US$57 Million In Venture Financing 10
Dompe Farmaceutici Enters Into Co-Development Agreement With SatRx For Reparixin 12
Dompe Farmaceutici Extends Drug Discovery Collaboration With Axxam 14
Scil Proteins Enters Into Licensing Agreement With Anabasis 15
Dompe Enters Into Licensing Agreement With Anabasis 16
Advanced Accelerator Acquires Rights To Fabovar From Dompe 17
Dompe Acquires Remaining 51% Stake In Anabasis 19
Biogen Idec Acquires Remaining JV Stake In Biogen Dompe From Dompe 21
Dompe Farmaceutici Acquires 49% Stake In Anabasis, BioPharma Company 23
Dompe Farmaceutici S.p.A., Key Competitors 24
Dompe Farmaceutici S.p.A., Key Employees 25
Dompe Farmaceutici S.p.A., Other Locations 26
Dompe Farmaceutici S.p.A., Subsidiaries 26

List of Figures
Dompe Farmaceutici S.p.A., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 1
Dompe Farmaceutici S.p.A., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 1
Dompe Farmaceutici S.p.A., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 1
Dompe Farmaceutici S.p.A., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 1
Dompe Farmaceutici S.p.A., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 5
Dompe Farmaceutici S.p.A., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 6
Dompe Farmaceutici S.p.A., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015 7
Dompe Farmaceutici S.p.A., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015 8

★調査レポート[Dompe Farmaceutici S.p.A.(製薬・医療分野):企業M&A動向] (コード:GDPH182029D)販売に関する免責事項を必ずご確認ください。
★調査レポート[Dompe Farmaceutici S.p.A.(製薬・医療分野):企業M&A動向]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆